Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N2O in Chronic Neuropathic Pain
NCT02246517Phase 1Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nitrous oxide in neuropathic pain (2 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Visual Analog Scale for Pain at 4 weeks. Status: unknown.
02
Drugs
nitrous oxide
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02246517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02246517.